Impact GLP-1 Agonists Following Bariatric
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT06132477
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- University of Missouri-Columbia
- Registry
-
NCT06132477
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT06132477. Randomized; no masking; primary purpose treatment. Start 2024-02-01 (actual); primary completion 2028-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact GLP-1 Agonists Following Bariatric
- Condition
- Morbid Obesity
- Condition
- Metabolic Syndrome
- Condition
- Diabetes Mellitus
- Condition
- Hypertension
- Condition
- Obstructive Sleep Apnea of Adult
- Intervention (Drug)
- GLP-1 receptor agonist
- Lead sponsor
- University of Missouri-Columbia
- Collaborator
- American Society for Metabolic and Bariatric Surgery
Record details
- Record id
cardio:ct-nct06132477- Content hash
84307975ea6459f49f32f1bc4634a6af7ae7a4b4841514390ed2980f7b71f81d